Immediate results and clinical follow-up of patients treated with drug eluting stents implantation in routine clinical practice;Résultats immédiats et suivi clinique des patients traités par implantation de stents actifs en pratique courante

Annales de Cardiologie et d'Angeiologie

Volumn 55, Issue 4, 2006, Pages 199-203

  Vochelet, F ^a   Tron, C ^a   Eltchaninoff, H ^a   Sebagh, L ^a   Tavildari, A ^a   Cribier, A ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Coronary angioplasty; Drug eluting stents; Restenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; POPULATION; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; THORAX PAIN; TIME SERIES ANALYSIS; TREATMENT INDICATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 33746029950     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2006.01.003     Document Type: Article

References (24)

1. Serruys P.W., de Jaegere P., Kiemeneij F., et al., for The Benestent Study Group. A Comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 331 (1994) 489-495
2. Fischman D.L., Leon M.B., Baim D.S., et al., for The Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331 (1994) 496-501
3. Serruys P.W., Van Hout B., Bonnier H., et al., for the Benestent Study Group. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352 (1998) 673-681
4. Sousa J.E., Costa M.A., Abizaid A.C., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting-stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
5. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346 (2002) 1773-1780
6. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents vs standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349 (2003) 1315-1323
7. Grube E., Silber S., Hauptmann K.E., et al. TAXUS I: six-and-twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
8. Stone G.W., Ellis S.G., Cox D.A., et al. TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
9. Chevalier B., Eltchaninoff H., Blanchard D., et al. De l'usage des endoprothèses coronaires. Arch Mal Cœur 96 (2003) 163-174
10. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N. Engl. J. Med. 348 (2003) 1537-1545
11. Aoki J., Ong A.T.L., Arampatzis C.A., et al. Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial). Am. J. Cardiol. 94 (2004) 627-631
12. Lemos P.A., Serruys P.W., Van Domburg R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "Real world". The rapamycin-eluting stent evaluated at rotterdam cardiology hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
13. Muni N.I., and Gross T.P. Problems with drug-eluting coronary stents, The FDA perspective. N. Engl. J. Med. 351 (2004) 1593-1595
14. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
15. Regar E., Lemos P.A., Saia F., et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am. J. Cardiol. 93 (2004) 1271-1275
16. Babapulle M.N., Joseph L., Bélisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
17. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
18. Monassier J.P. Les stents à relargage de drogues : bis repetita ?. Arch Mal Cœur 95 (2002) 761-762
19. Lablanche J.M. Stent à libération de médicament, un progrès inestimable. Arch Mal Cœur 96 (2003) 161-162
20. Saia F., Lemos P.A., Arampatzis C.A., et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Heart 90 (2004) 1183-1188
21. Colombo A., Moses J.W., Morice M.C., et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesion. Circulation 109 (2004) 1244-1249
22. Hoye A., Tanabe K., Lemos P.A., et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J. Am. Coll. Cardiol. 43 (2004) 1954-1958
23. Arampatzis C.A., Lemos P.A., Tanabe K., et al. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am. J. Cardiol. 92 (2003) 327-329
24. Hoye A., Lemos P.A., Arampatzis C.A., et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J. Invasive Cardiol. 16 (2004) 234-235